Turner Syndrome
A syndrome of defective gonadal development in phenotypic females associated with the karyotype 45,X (or 45,XO). Patients generally are of short stature with undifferentiated GONADS (streak gonads), SEXUAL INFANTILISM, HYPOGONADISM, webbing of the neck, cubitus valgus, elevated GONADOTROPINS, decreased ESTRADIOL level in blood, and CONGENITAL HEART DEFECTS. NOONAN SYNDROME (also called Pseudo-Turner Syndrome and Male Turner Syndrome) resembles this disorder; however, it occurs in males and females with a normal karyotype and is inherited as an autosomal dominant.
Drugs by status
Approved for this indication (2)
Phase 4 trials (4)
Phase 2 trials (3)
Other trials (1)
Organizations
Organization Involved with Phase 4 Indications (12)
Organization Involved with Phase 3 Indications (14)
- Ipsen
- Dong-A Pharmaceutical
- National Institute of Neurological Disorders and Stroke (NINDS)
- Ajou University
- Korea University
- Seoul National University
- Yonsei University
- Chonbuk National University
- University of Ulsan
- Catholic University of Korea
- Kyungpook University
- Chonnam National University
- Ferring
- Pusan National University
Organization Involved with Phase 2 Indications (10)
Organization Involved with Phase 1 Indications (6)
Organization Involved with Other Experimental Indications (3)